How to manage a child’s pain? September is #sicklecellawarenessmonth . We at #CSL are working on new treatments for #sicklecelldisease cslbehring.com/vita/2022/3-vi…

No adult left behind: bridge the health-care gap for #SickleCell disease from the #CSL-sponsored special issue. #SickleCellAwarenessMonth nature.com/articles/d4158…

Congratulations to my new colleagues Naja Nyffenegger and Vania Manolova at CSL Vifor for the recently released #podcast on the exciting science behind vamifeport, a new ferroportin inhibitor being developed for #sicklecelldisease! share.transistor.fm/s/d105b74b

Thank you Sickle Cell Anemia News for amplifying our data! Very timely as we gather for #ASN2022 sicklecellanemianews.com/news/sickle-ce…

Nature’s beauty shown in amazing photomicrographs: nikonsmallworld.com/galleries/2022…

VOTE today. Make sure everyone you know also votes. Only hours now until polls close in the US. Vote.gov

ASH has adopted the term "classical hematology," in place of what was formerly referred to as "benign" or "nonmalignant." Discoveries within #classicalheme have significantly advanced the field & continue to better the lives of those living with non-cancerous blood disorders. 1/2

My dear friend Dr. Gbotosho. Just yesterday we were post docs in the laboratory of Dr. Kato, studying the mechanisms of sickle cell pulmonary hypertension one RT PCR assay at a time. ⁦Gregory Kato, MD⁩ #womeninscience #womeninmedicine #ASH22 #sicklecelldisease

Thanks to Nature Reviews Disease Primers for making access free to all for our 2018 review article #SickleCellDisease, so far accessed 89k and cited 494 times. nature.com/articles/nrdp2…

Dr Saro Armenian is the recipient of the ASPHO 2023 Frank A. Oski Lectureship. This has great personal meaning to me--I cared for Saro's sister while I was fellow and faculty in Frank's department at Johns Hopkins American Society of Pediatric Hematology/Oncology City of Hope Saro Armenian bit.ly/2ERQIP8

FDA approved the lovo-cel gene therapy for SCD. Sick Cells is pleased to see this life-saving therapy come to market. This is an important step for the future of care for people and families living with SCD. Watch the press briefing here at 12:30 PM Et: bit.ly/3RdpLMU

We are very excited to share that today, Dec. 8, the Food and Drug Administration approved two gene therapies to treat sickle cell disease! These potentially curative therapies are the first treatments of their kind available to individuals with SCD. fda.gov/news-events/pr…

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease fda.gov/news-events/pr…

#advocate4sicklecell #curesicklecell

Big day for SCD with two new approved gene therapies from BlueBird Bio-lentiviral gene addition & Vertex CRISPR gene inactivation #SCD #ash2023

The #SNL skit brought welcome attention to #sicklecell disease, it also demonstrated the need for more nuanced education and discussions about this condition and the new therapies that were recently approved by the U.S. FDA. Video Credit: Saturday Night Live - SNL NBC Entertainment Peacock #sicklecell101

SCDAA is disappointed by the Saturday Night Live - SNL skit about the recent historic approvals of potentially curative gene therapies for #SCD. SNL chose to cast a spotlight on this news with a tone-deaf skit that is distasteful at best and harmful at worst. Read more: buff.ly/3Rv3Uk5

Lately, it seems one of the only times sickle cell is brought up is in a joke. WE ARE TIRED. #SICKLECELLISNOTAJOKE 🩸

September is National #SickleCellAwarenessMonth! ASH is honored to continue its dedication to #ConquerSCD. Follow along this month, to learn about initiatives by ASH and its members to improve outcomes of individuals living with #sicklecell Learn more: ow.ly/eRHE50TbQlk

September is National #SickleCellAwarenessMonth. To help support awareness, our 2018 review article on #SickleCellDisease is free to access. The contributions by my authoritative co-authors have made it my most highly cited article! rdcu.be/dSSIO